BioSmartLtd Past Earnings Performance

Past criteria checks 0/6

BioSmartLtd has been growing earnings at an average annual rate of 7.1%, while the Tech industry saw earnings growing at 14.9% annually. Revenues have been growing at an average rate of 25.9% per year.

Key information

7.08%

Earnings growth rate

4.65%

EPS growth rate

Tech Industry Growth-2.85%
Revenue growth rate25.86%
Return on equity-0.61%
Net Margin-0.46%
Last Earnings Update31 Mar 2025

Recent past performance updates

Shareholders In BioSmartLtd (KOSDAQ:038460) Should Look Beyond Earnings For The Full Story

Mar 26
Shareholders In BioSmartLtd (KOSDAQ:038460) Should Look Beyond Earnings For The Full Story

Recent updates

The Market Lifts BioSmart Co.,Ltd. (KOSDAQ:038460) Shares 33% But It Can Do More

Apr 23
The Market Lifts BioSmart Co.,Ltd. (KOSDAQ:038460) Shares 33% But It Can Do More

Is BioSmartLtd (KOSDAQ:038460) Using Too Much Debt?

Apr 09
Is BioSmartLtd (KOSDAQ:038460) Using Too Much Debt?

BioSmart Co.,Ltd. (KOSDAQ:038460) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Nov 13
BioSmart Co.,Ltd. (KOSDAQ:038460) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Here's Why We Think BioSmartLtd (KOSDAQ:038460) Is Well Worth Watching

Oct 14
Here's Why We Think BioSmartLtd (KOSDAQ:038460) Is Well Worth Watching

BioSmartLtd (KOSDAQ:038460) Seems To Be Using A Lot Of Debt

Aug 01
BioSmartLtd (KOSDAQ:038460) Seems To Be Using A Lot Of Debt

BioSmart Co.,Ltd. (KOSDAQ:038460) Might Not Be As Mispriced As It Looks After Plunging 26%

Jun 15
BioSmart Co.,Ltd. (KOSDAQ:038460) Might Not Be As Mispriced As It Looks After Plunging 26%

Here's Why BioSmartLtd (KOSDAQ:038460) Has A Meaningful Debt Burden

May 02
Here's Why BioSmartLtd (KOSDAQ:038460) Has A Meaningful Debt Burden

Further Upside For BioSmart Co.,Ltd. (KOSDAQ:038460) Shares Could Introduce Price Risks After 52% Bounce

Apr 11
Further Upside For BioSmart Co.,Ltd. (KOSDAQ:038460) Shares Could Introduce Price Risks After 52% Bounce

Shareholders In BioSmartLtd (KOSDAQ:038460) Should Look Beyond Earnings For The Full Story

Mar 26
Shareholders In BioSmartLtd (KOSDAQ:038460) Should Look Beyond Earnings For The Full Story

Is BioSmartLtd (KOSDAQ:038460) Using Too Much Debt?

Mar 09
Is BioSmartLtd (KOSDAQ:038460) Using Too Much Debt?

Returns On Capital At BioSmartLtd (KOSDAQ:038460) Paint An Interesting Picture

Feb 16
Returns On Capital At BioSmartLtd (KOSDAQ:038460) Paint An Interesting Picture

Declining Stock and Decent Financials: Is The Market Wrong About BioSmart Co.,Ltd. (KOSDAQ:038460)?

Jan 29
Declining Stock and Decent Financials: Is The Market Wrong About BioSmart Co.,Ltd. (KOSDAQ:038460)?

BioSmartLtd (KOSDAQ:038460) Shareholders Have Enjoyed A 51% Share Price Gain

Jan 11
BioSmartLtd (KOSDAQ:038460) Shareholders Have Enjoyed A 51% Share Price Gain

BioSmart Co.,Ltd. (KOSDAQ:038460) Looks Interesting, And It's About To Pay A Dividend

Dec 23
BioSmart Co.,Ltd. (KOSDAQ:038460) Looks Interesting, And It's About To Pay A Dividend

Does BioSmart Co.,Ltd. (KOSDAQ:038460) Have A Place In Your Dividend Portfolio?

Dec 17
Does BioSmart Co.,Ltd. (KOSDAQ:038460) Have A Place In Your Dividend Portfolio?

These 4 Measures Indicate That BioSmartLtd (KOSDAQ:038460) Is Using Debt Extensively

Nov 29
These 4 Measures Indicate That BioSmartLtd (KOSDAQ:038460) Is Using Debt Extensively

Revenue & Expenses Breakdown

How BioSmartLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A038460 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 25477,902-2,20859,749766
31 Dec 24484,31012759,072680
30 Sep 24477,3377,12857,621959
30 Jun 24472,3108,96058,929966
31 Mar 24464,37719,48261,6501,120
31 Dec 23456,16417,90764,1401,341
30 Sep 23451,6934,46465,8881,468
30 Jun 23430,6186,12165,3301,607
31 Mar 23409,3442,03864,3971,320
31 Dec 22391,82272162,7031,168
30 Sep 22332,8562,35460,209386
30 Jun 22287,7361,08458,968225
31 Mar 22237,7882,90956,485327
31 Dec 21189,1831,39256,413427
30 Sep 21184,940-5,44058,507804
30 Jun 21175,807-6,89158,0591,051
31 Mar 21167,868-9,99057,8301,088
31 Dec 20166,429-8,73755,5911,029
30 Sep 20166,3953,24756,345930
30 Jun 20167,21219,93054,695690
31 Mar 20165,73220,84252,595569
31 Dec 19158,96822,14749,542477
30 Sep 19151,42618,04645,517412
30 Jun 19143,9274,64641,389524
31 Mar 19129,5296,74435,709534
31 Dec 18117,7335,13531,412534
30 Sep 18103,1088,64525,604565
30 Jun 1892,4987,69121,079384
31 Mar 1887,4895,58518,848255
31 Dec 1780,4334,82616,992168
30 Sep 1779,5132,59415,37592
30 Jun 1774,7801,69714,28449
31 Mar 1768,02749513,09373
31 Dec 1662,99061911,90179
30 Sep 1658,8151,61911,97697
30 Jun 1655,9462,13412,127102
31 Mar 1655,2041,61912,10796
31 Dec 1554,1873,14811,61688
30 Sep 1550,6362,17810,69172
30 Jun 1546,4686509,64567
31 Mar 1541,4671,7979,13052
31 Dec 1441,5047439,31350
30 Sep 1452,197-70111,116107
30 Jun 1452,598-23111,101104

Quality Earnings: A038460 is currently unprofitable.

Growing Profit Margin: A038460 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A038460 is unprofitable, but has reduced losses over the past 5 years at a rate of 7.1% per year.

Accelerating Growth: Unable to compare A038460's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A038460 is unprofitable, making it difficult to compare its past year earnings growth to the Tech industry (53.9%).


Return on Equity

High ROE: A038460 has a negative Return on Equity (-0.61%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/09 08:36
End of Day Share Price 2025/06/09 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioSmart Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.